3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Gastrointestinal
1
Conditions
Motor Activity
3
Prostatic Neoplasms
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Stomach Neoplasms
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Lupus Erythematosus, Systemic
1
Lung Neoplasms
1
Hodgkin Disease
1
Gastrointestinal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
enzalutamide
92
Magnetic Resonance Spectroscopy
87
Specimen Handling
66
Prednisone
65
Androgen Antagonists
59
Abiraterone Acetate
59
apalutamide
56
Radiosurgery
53
Radiotherapy
47
Leuprolide
47
darolutamide
46
abiraterone
44
Docetaxel
43
Radiation
31
Pluvicto
31
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
30
Biopsy
30
relugolix
28
Surveys and Questionnaires
28
pembrolizumab
26
gallium 68 PSMA-11
26
Standard of Care
26
Triptorelin Pamoate
25
Goserelin
25
bicalutamide
23
Gonadotropin-Releasing Hormone
23
Brachytherapy
21
Carboplatin
20
X-Rays
19
luprolide acetate gel depot
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
High-Intensity Interval Training
×
1 year
×
Clear all
NCT04558398
2026-04-29
ICCE-Mito
University of Nottingham
Phase NA
Completed
15 enrolled
NCT07518888
2026-04-09
ESCAPE
University of Miami
Phase NA
Not yet recruiting
49 enrolled